Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors
Naoya Kitamura(University of Arizona), Jun Wang(Rutgers Sexual and Reproductive Health and Rights), Adis Kukuljac(University of South Florida), M. Sacco(University of South Florida), Julia A. Townsend(University of Arizona), Sara Cherry(California University of Pennsylvania), Yanmei Hu(University of Arizona), Chunlong Ma(University of Arizona), D. Schultz(University of Evansville), Yan Xiang(Sichuan University), Tommy Szeto(University of Arizona), Fushun Zhang(The University of Texas at San Antonio Health Science Center), Michael T. Marty(University of Arizona), Yu Chen(University of South Florida), Mandy Ba(University of Arizona), Xiujun Zhang(University of South Florida), Xiangzhi Meng(University of California, Los Angeles)
Cited by 168
Related Papers
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins
|Genes & Development|2002|1.3k
Targeting histone deacetylase complexes via KRAB-zinc finger proteins: the PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2α subunit of NuRD
|Genes & Development|2001|523